公式財務諸表に基づく売上高、利益、キャッシュフローの推移。
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→
| 損益計算書 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高合計 | $21.0B | $20.1B | $16.7B | $14.2B | $12.7B | $11.9B | $9.9B | $10.7B | $9.8B | $9.0B | $8.4B | $7.5B | $7.4B | $7.1B | $7.2B | $7.6B | $7.8B | $8.2B | $8.1B | $8.4B | $7.8B |
| 売上総利益 | $14.9B | $13.9B | $10.3B | $8.8B | $7.7B | $7.5B | $5.6B | $6.9B | $6.5B | $5.9B | $5.3B | $4.6B | $4.6B | $4.5B | $4.6B | $4.7B | $4.8B | $5.2B | $5.1B | $5.4B | $5.1B |
| 売上総利益率 % | 71.2% | 69.0% | 61.3% | 62.0% | 60.8% | 62.8% | 56.2% | 64.1% | 65.9% | 64.9% | 63.7% | 61.0% | 62.2% | 63.5% | 62.9% | 61.4% | 61.3% | 63.2% | 63.2% | 64.6% | 65.0% |
| 営業利益（EBIT） | $4.6B | $4.0B | $2.6B | $2.2B | $1.8B | $1.9B | $601M | $1.7B | $1.7B | $1.5B | $1.2B | $790M | $845M | $871M | $994M | $1.1B | $1.1B | $1.3B | $1.3B | $1.2B | $1.2B |
| 営業利益率 % | 21.8% | 19.8% | 15.7% | 15.3% | 14.4% | 16.2% | 6.1% | 16.0% | 17.7% | 16.9% | 14.7% | 10.6% | 11.5% | 12.2% | 13.7% | 14.7% | 13.8% | 15.9% | 16.1% | 14.1% | 15.8% |
| 当期純利益 | $3.7B | $2.9B | $1.9B | $1.6B | $698M | $1.0B | ($82M) | $4.7B | $1.7B | $104M | $347M | ($239M) | ($119M) | ($121M) | ($4.1B) | $441M | ($1.1B) | ($1.0B) | ($2.0B) | ($495M) | ($3.6B) |
| 純利益率 % | 17.5% | 14.4% | 11.1% | 11.2% | 5.5% | 8.8% | -0.8% | 43.8% | 17.0% | 1.1% | 4.1% | -3.2% | -1.6% | -1.7% | -56.1% | 5.8% | -13.6% | -12.5% | -25.3% | -5.9% | -45.7% |
| EBITDA | — | $5.1B | $3.9B | $3.5B | $2.7B | $2.5B | $1.5B | $2.2B | $2.6B | $2.0B | $1.2B | $360M | $433M | $721M | ($3.2B) | $1.6B | $149M | ($108M) | ($699M) | $940M | ($2.3B) |
| 1株当たり利益（EPS） | $2.45 | $1.93 | $1.25 | $1.09 | $0.48 | $0.73 | $-0.06 | $3.33 | $1.19 | $0.07 | $0.25 | $-0.18 | $-0.09 | $-0.09 | $-2.89 | $0.29 | $-0.70 | $-0.68 | $-1.36 | $-0.33 | $-2.81 |
| 発行済株式数（百万株） | — | 1,494M | 1,486M | 1,464M | 1,440M | 1,434M | 1,417M | 1,411M | 1,401M | 1,393M | 1,377M | 1,341M | 1,348M | 1,341M | 1,407M | 1,519M | 1,518M | 1,508M | 1,498M | 1,487M | 1,274M |
出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。
貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は BSX のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/BSX
本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。
About TickerBase · Data methodology & sources · Privacy · Terms